loading
Dr Reddys Laboratories Ltd Adr stock is traded at $13.40, with a volume of 2.67M. It is up +1.67% in the last 24 hours and up +2.92% over the past month. Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
See More
Previous Close:
$13.18
Open:
$13.54
24h Volume:
2.67M
Relative Volume:
1.37
Market Cap:
$11.65B
Revenue:
$3.47B
Net Income/Loss:
$668.83M
P/E Ratio:
3.3394
EPS:
4.0127
Net Cash Flow:
$253.46M
1W Performance:
-4.29%
1M Performance:
+2.92%
6M Performance:
-11.32%
1Y Performance:
-3.54%
1-Day Range:
Value
$13.36
$13.74
1-Week Range:
Value
$13.17
$13.99
52-Week Range:
Value
$12.26
$16.89

Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile

Name
Name
Dr Reddys Laboratories Ltd Adr
Name
Phone
-
Name
Address
-
Name
Employee
27,048
Name
Twitter
@drreddys
Name
Next Earnings Date
2025-01-23
Name
Latest SEC Filings
Name
RDY's Discussions on Twitter

Compare RDY with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
RDY
Dr Reddys Laboratories Ltd Adr
13.40 11.65B 3.47B 668.83M 253.46M 4.0127
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
159.27 70.23B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.74 48.23B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.36 48.22B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.93 18.57B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
301.42 13.29B 2.76B 1.11B 898.10M 22.77

Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-19-24 Downgrade Nomura Buy → Neutral
Jan-11-24 Downgrade Jefferies Buy → Underperform
Aug-29-23 Downgrade HSBC Securities Buy → Hold
May-18-23 Downgrade Bernstein Outperform → Mkt Perform
Mar-17-23 Upgrade BofA Securities Neutral → Buy
Jan-30-23 Initiated JP Morgan Underweight
Nov-14-22 Downgrade Credit Suisse Neutral → Underperform
Jan-03-22 Resumed BofA Securities Neutral
Jul-27-21 Downgrade Credit Suisse Outperform → Neutral
Feb-02-21 Upgrade Barclays Equal Weight → Overweight
Sep-18-20 Upgrade BofA Securities Neutral → Buy
Sep-18-20 Upgrade Investec Sell → Hold
Jan-28-20 Downgrade CLSA Buy → Outperform
Jan-27-20 Downgrade CLSA Buy → Outperform
Jan-09-20 Upgrade Citigroup Sell → Buy
Nov-04-19 Downgrade BofA/Merrill Buy → Neutral
Sep-04-19 Upgrade Credit Suisse Underperform → Outperform
Jul-01-19 Upgrade Macquarie Neutral → Outperform
Jun-20-19 Initiated Deutsche Bank Hold
Jun-11-19 Initiated Barclays Equal Weight
May-20-19 Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-19-19 Upgrade CLSA Outperform → Buy
Jan-17-19 Downgrade Citigroup Neutral → Sell
Sep-21-17 Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-31-17 Upgrade CLSA Underperform → Outperform
Jul-28-17 Downgrade CLSA Underperform → Sell
Jul-27-16 Downgrade HSBC Securities Hold → Reduce
Jul-27-16 Downgrade Jefferies Hold → Underperform
Feb-10-16 Upgrade Credit Agricole Underperform → Buy
Nov-10-15 Downgrade Citigroup Buy → Neutral
View All

Dr Reddys Laboratories Ltd Adr Stock (RDY) Latest News

pulisher
May 09, 2025

Dr. Reddy’s Laboratories Grants Stock Options to Employees in May 2025 - TipRanks

May 09, 2025
pulisher
May 09, 2025

Asian Equities Climb Despite Weekly Losses - Finimize

May 09, 2025
pulisher
May 09, 2025

Insider’s View: Deciphering Six Flags Entertainment Corp (FUN)’s Financial Health Through Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Balance Sheet Breakdown: Astrazeneca plc ADR (AZN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Ratio Examination: Dr. Reddy’s Laboratories Ltd. ADR (RDY)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 09, 2025
pulisher
May 09, 2025

Metric Deep Dive: Understanding Phio Pharmaceuticals Corp (PHIO) Through its Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Financial Analysis: Spotify Technology S.A (SPOT)’s Ratios Unveil Key Insights - DWinneX

May 09, 2025
pulisher
May 09, 2025

5 Indian ADRs crash up to 14% amid rising India-Pakistan military conflict - Trade Brains

May 09, 2025
pulisher
May 08, 2025

Indian Markets Set for Bloody Friday as Gift Nifty Signals Sharp Gap-Down Open Amid Escalating India-Pak Tensions - outlookbusiness.com

May 08, 2025
pulisher
May 08, 2025

Indian ADRs slump as India-Pakistan conflict sees escalation - Moneycontrol

May 08, 2025
pulisher
May 05, 2025

Validea's Top Health Care Stocks Based On Peter Lynch5/5/2025 - Nasdaq

May 05, 2025
pulisher
Apr 25, 2025

Asian ADRs See Mixed Results Despite Weekly Gains - Finimize

Apr 25, 2025
pulisher
Apr 25, 2025

Dr. Reddy’s Laboratories Ltd. ADR (RDY) Performance and Fundamentals Dashboard tells a completely different story - Sete News

Apr 25, 2025
pulisher
Apr 24, 2025

Dr. Reddy’s Looks Well Positioned for Long-Term Growth, Aided by Acquisitions and Partnerships - Morningstar

Apr 24, 2025
pulisher
Apr 23, 2025

Investing in Dr. Reddy’s Laboratories Ltd. ADR (RDY): What You Must Know - knoxdaily.com

Apr 23, 2025
pulisher
Apr 20, 2025

LLY Stock Quote Price and Forecast - CNN

Apr 20, 2025
pulisher
Apr 17, 2025

NVO Stock Quote Price and Forecast - CNN

Apr 17, 2025
pulisher
Apr 16, 2025

Zacks Industry Outlook Dr. Reddy's, Sandoz And Teva Pharmaceuticals - Barchart.com

Apr 16, 2025
pulisher
Apr 16, 2025

Asian ADRs Climb, Showcasing North And South Asia Performances - Finimize

Apr 16, 2025
pulisher
Apr 14, 2025

PDD Holdings Stock Delivers Phenomenal 5.82% Surge to $95.77 on April 14 – Bullish Momentum Lifts Chinese Tech - Hindustan Herald

Apr 14, 2025
pulisher
Apr 14, 2025

3 Generic Drug Stocks To Watch Amid Trade War Jitters & Inflation Woes - Barchart.com

Apr 14, 2025
pulisher
Apr 14, 2025

Dr Reddy’s may cut workforce by 25%, including those in Rs 1 crore bracket: Report - The Financial Express

Apr 14, 2025
pulisher
Apr 12, 2025

Asian ADRs Shine As Zai Lab And CNFinance Lead The Gains - Finimize

Apr 12, 2025
pulisher
Apr 12, 2025

Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by Massachusetts Financial Services Co. MA - MarketBeat

Apr 12, 2025
pulisher
Apr 11, 2025

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - TradingView

Apr 11, 2025
pulisher
Apr 11, 2025

Mixed Performance For Asian Stocks Traded On US Markets - Finimize

Apr 11, 2025
pulisher
Apr 11, 2025

Vanguard Group Inc. Purchases 3,911,404 Shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY) - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Asian Equities Traded in the US as American Depositary Receipts Tumble in Thursday Trading - TradingView

Apr 10, 2025
pulisher
Apr 09, 2025

Pinpoint Asset Management Ltd Acquires 473,000 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat

Apr 09, 2025
pulisher
Apr 08, 2025

Dr Reddy's Slapped Rs 2,395 Cr Income Tax Notice, Pharma Giant Denies Allegations - Medical Dialogues

Apr 08, 2025
pulisher
Apr 07, 2025

Asian Equities Traded in the US as American Depositary Receipts Sharply Lower in Monday Trading - TradingView

Apr 07, 2025
pulisher
Apr 06, 2025

Stocks to watch, April 7: IT, pharma, metals, oil-sensitive stocks, Nykaa, Dr Reddy's, Delhivery, Trent Ltd, and more - Upstox

Apr 06, 2025
pulisher
Apr 05, 2025

Dr Reddy's gets over Rs 2,395 crore show cause notice from I-T authority - Moneycontrol

Apr 05, 2025
pulisher
Apr 04, 2025

TCS, Dr Reddy's Labs among 6 large and mid-cap stocks that hit 52-week lows on Friday - The Economic Times

Apr 04, 2025
pulisher
Apr 03, 2025

Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - TradingView

Apr 03, 2025
pulisher
Apr 03, 2025

Sensex Today | Stock Market Highlights: Sensex falls 322 points, Nifty slips 82 points as IT drags - CNBC TV18

Apr 03, 2025
pulisher
Apr 02, 2025

Asian Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading - TradingView

Apr 02, 2025
pulisher
Apr 02, 2025

Generics Industry: India Celebrates Pharmaceutical Tariffs Exemption but Uncertainty Remains High - Morningstar

Apr 02, 2025
pulisher
Apr 01, 2025

US Tariffs on Pharma: Zydus, Dr Reddy’s at highest risk, says Jefferies; Check impact on other Indian pharma stocks - Mint

Apr 01, 2025
pulisher
Mar 29, 2025

Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by GQG Partners LLC - MarketBeat

Mar 29, 2025
pulisher
Mar 27, 2025

American Healthcare REIT Inc (AHR) Stock: A Year of Decreases and Increases - The InvestChronicle

Mar 27, 2025
pulisher
Mar 27, 2025

Asian Equities Traded in the US as ADRs Rise in Tuesday Trading - MSN

Mar 27, 2025
pulisher
Mar 26, 2025

Top Indian ADRs by Market Cap: HDFC Bank, ICICI Bank & More - INDmoney

Mar 26, 2025
pulisher
Mar 25, 2025

Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - TradingView

Mar 25, 2025
pulisher
Mar 24, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Mar 24, 2025
pulisher
Mar 21, 2025

Asian Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - TradingView

Mar 21, 2025
pulisher
Mar 20, 2025

Infosys, Wipro, TCS, other IT stocks fall up to 3% after Accenture Q2 results. Details here - Mint

Mar 20, 2025

Dr Reddys Laboratories Ltd Adr Stock (RDY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$115.71
price down icon 1.54%
$8.77
price down icon 3.52%
$301.42
price down icon 2.14%
$81.74
price up icon 1.62%
$30.13
price down icon 0.82%
Cap:     |  Volume (24h):